248 related articles for article (PubMed ID: 24463292)
1. Regulation of an autoimmune model for multiple sclerosis in Th2-biased GATA3 transgenic mice.
Fernando V; Omura S; Sato F; Kawai E; Martinez NE; Elliott SF; Yoh K; Takahashi S; Tsunoda I
Int J Mol Sci; 2014 Jan; 15(2):1700-18. PubMed ID: 24463292
[TBL] [Abstract][Full Text] [Related]
2. Enforced expression of GATA3 allows differentiation of IL-17-producing cells, but constrains Th17-mediated pathology.
van Hamburg JP; de Bruijn MJ; Ribeiro de Almeida C; van Zwam M; van Meurs M; de Haas E; Boon L; Samsom JN; Hendriks RW
Eur J Immunol; 2008 Sep; 38(9):2573-86. PubMed ID: 18792410
[TBL] [Abstract][Full Text] [Related]
3. IL-12p35-deficient mice are susceptible to experimental autoimmune encephalomyelitis: evidence for redundancy in the IL-12 system in the induction of central nervous system autoimmune demyelination.
Gran B; Zhang GX; Yu S; Li J; Chen XH; Ventura ES; Kamoun M; Rostami A
J Immunol; 2002 Dec; 169(12):7104-10. PubMed ID: 12471147
[TBL] [Abstract][Full Text] [Related]
4. Role of Th17 cells in the pathogenesis of CNS inflammatory demyelination.
Rostami A; Ciric B
J Neurol Sci; 2013 Oct; 333(1-2):76-87. PubMed ID: 23578791
[TBL] [Abstract][Full Text] [Related]
5. Augmenting DAF levels in vivo ameliorates experimental autoimmune encephalomyelitis.
Li Q; Huang D; Nacion K; Bu H; Lin F
Mol Immunol; 2009 Sep; 46(15):2885-91. PubMed ID: 19660813
[TBL] [Abstract][Full Text] [Related]
6. 5-aminoimidazole-4-carboxamide ribonucleoside: a novel immunomodulator with therapeutic efficacy in experimental autoimmune encephalomyelitis.
Nath N; Giri S; Prasad R; Salem ML; Singh AK; Singh I
J Immunol; 2005 Jul; 175(1):566-74. PubMed ID: 15972693
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory role of CD19 in the progression of experimental autoimmune encephalomyelitis by regulating cytokine response.
Matsushita T; Fujimoto M; Hasegawa M; Komura K; Takehara K; Tedder TF; Sato S
Am J Pathol; 2006 Mar; 168(3):812-21. PubMed ID: 16507897
[TBL] [Abstract][Full Text] [Related]
8. Enforced expression of GATA-3 in transgenic mice inhibits Th1 differentiation and induces the formation of a T1/ST2-expressing Th2-committed T cell compartment in vivo.
Nawijn MC; Dingjan GM; Ferreira R; Lambrecht BN; Karis A; Grosveld F; Savelkoul H; Hendriks RW
J Immunol; 2001 Jul; 167(2):724-32. PubMed ID: 11441076
[TBL] [Abstract][Full Text] [Related]
9. Gene Expression in Spontaneous Experimental Autoimmune Encephalomyelitis Is Linked to Human Multiple Sclerosis Risk Genes.
Faber H; Kurtoic D; Krishnamoorthy G; Weber P; Pütz B; Müller-Myhsok B; Weber F; Andlauer TFM
Front Immunol; 2020; 11():2165. PubMed ID: 33072080
[TBL] [Abstract][Full Text] [Related]
10. Erythropoietin enhances endogenous haem oxygenase-1 and represses immune responses to ameliorate experimental autoimmune encephalomyelitis.
Chen SJ; Wang YL; Lo WT; Wu CC; Hsieh CW; Huang CF; Lan YH; Wang CC; Chang DM; Sytwu HK
Clin Exp Immunol; 2010 Nov; 162(2):210-23. PubMed ID: 21069936
[TBL] [Abstract][Full Text] [Related]
11. Limiting multiple sclerosis related axonopathy by blocking Nogo receptor and CRMP-2 phosphorylation.
Petratos S; Ozturk E; Azari MF; Kenny R; Lee JY; Magee KA; Harvey AR; McDonald C; Taghian K; Moussa L; Mun Aui P; Siatskas C; Litwak S; Fehlings MG; Strittmatter SM; Bernard CC
Brain; 2012 Jun; 135(Pt 6):1794-818. PubMed ID: 22544872
[TBL] [Abstract][Full Text] [Related]
12. Cellular FLIP (long isoform) overexpression in T cells drives Th2 effector responses and promotes immunoregulation in experimental autoimmune encephalomyelitis.
Tseveleki V; Bauer J; Taoufik E; Ruan C; Leondiadis L; Haralambous S; Lassmann H; Probert L
J Immunol; 2004 Dec; 173(11):6619-26. PubMed ID: 15557152
[TBL] [Abstract][Full Text] [Related]
13. Myelin oligodendrocyte glycoprotein (MOG35-55)-induced experimental autoimmune encephalomyelitis is ameliorated in interleukin-32 alpha transgenic mice.
Yun J; Gu SM; Yun HM; Son DJ; Park MH; Lee MS; Hong JT
Oncotarget; 2015 Dec; 6(38):40452-63. PubMed ID: 26564962
[TBL] [Abstract][Full Text] [Related]
14. Inconsistence between number and function of autoreactive T cells in the course of experimental autoimmune encephalomyelitis.
Wan X; Pei W; Zhang Y; Zhang L; Shahzad KA; Xu T; Shen C
Immunol Invest; 2018 Jan; 47(1):1-17. PubMed ID: 28872930
[TBL] [Abstract][Full Text] [Related]
15. Modulatory effect of celastrol on Th1/Th2 cytokines profile, TLR2 and CD3+ T-lymphocyte expression in a relapsing-remitting model of multiple sclerosis in rats.
Abdin AA; Hasby EA
Eur J Pharmacol; 2014 Nov; 742():102-12. PubMed ID: 25218987
[TBL] [Abstract][Full Text] [Related]
16. Chronological changes of CD4(+) and CD8(+) T cell subsets in the experimental autoimmune encephalomyelitis, a mouse model of multiple sclerosis.
Sonobe Y; Jin S; Wang J; Kawanokuchi J; Takeuchi H; Mizuno T; Suzumura A
Tohoku J Exp Med; 2007 Dec; 213(4):329-39. PubMed ID: 18075237
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of IL-17 Serum Level, Brain Inflammation and Demyelination in Experimental Autoimmune Encephalomyelitis C57BL/6 Mice Model with Different Doses of Myelin Oligodendrocyte Glycoprotein.
Ghorbani MM; Farazmandfar T; Nasirikenari M; Abediankenari S; Meamarian A; Shahbazi M
Iran J Allergy Asthma Immunol; 2019 Jun; 18(3):300-309. PubMed ID: 31522437
[TBL] [Abstract][Full Text] [Related]
18. Role of IL-12 receptor beta 1 in regulation of T cell response by APC in experimental autoimmune encephalomyelitis.
Zhang GX; Yu S; Gran B; Li J; Siglienti I; Chen X; Calida D; Ventura E; Kamoun M; Rostami A
J Immunol; 2003 Nov; 171(9):4485-92. PubMed ID: 14568921
[TBL] [Abstract][Full Text] [Related]
19. Galectin isolated from parasite inhibits remission of experimental autoimmune encephalomyelitis by up-regulating autoantibody.
Bing SJ; Ha D; Ahn G; Cho J; Kim A; Park SK; Yu HS; Jee Y
Clin Exp Immunol; 2015 Jun; 180(3):419-31. PubMed ID: 25619397
[TBL] [Abstract][Full Text] [Related]
20. The innate immune adaptor MyD88 is dispensable for spontaneous autoimmune demyelination in a mouse model of multiple sclerosis.
Wexler AG; Frielle C; Berry G; Budgeon LR; Baccon J; Christensen ND; Waldner H
J Neuroimmunol; 2013 Feb; 255(1-2):60-9. PubMed ID: 23269203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
